Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ra Medical Systems Inc 1670 Highway 160 West Suite 205 Fort Mill SC 29708 USA

www.ramed.com P: 973-691-2000

Description:

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.

Key Statistics

Overview:

Market Capitalization, $K 3,188
Enterprise Value, $K -12,672
Shares Outstanding, K 5,368
Annual Sales, $ 10 K
Annual Net Income, $ -26,870 K
Last Quarter Sales, $ 90 K
Last Quarter Net Income, $ -66,400 K
60-Month Beta -0.03
% of Insider Shareholders 18.62%
% of Institutional Shareholders 11.00%
Float, K 4,368
% Float 81.38%
Short Volume Ratio 0.50

Growth:

1-Year Return -92.84%
3-Year Return -99.86%
5-Year Return 0.00%
5-Year Revenue Growth -99.83%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.86 on 11/14/22
Latest Earnings Date 08/21/23
Earnings Per Share ttm -11.36
EPS Growth vs. Prev Qtr 48.53%
EPS Growth vs. Prev Year 93.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 10/03/22

RMED Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -496.57%
Return-on-Assets % -344.49%
Profit Margin % -268,700.01%
Debt/Equity 0.00
Price/Sales 207.04
Price/Cash Flow N/A
Price/Book 0.09
Book Value/Share 6.68
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar